Johnson & Johnson MedTech Neurovascular Worldwide President Mark Dickinson is leaving J&J after a 26-year career.

Johnson & Johnson MedTech announced today that the FDA cleared its Monarch Quest technology for robotic-assisted bronchoscopy ...

Paradromics announced today that it selected investigators for an upcoming clinical study of its brain-computer interface ...

Spineart and eCential Robotics today announced the receipt of FDA 510(k) clearance for the use of an application for robotic ...

Lifeward announced today that it received FDA 510(k) clearance for its latest-generation personal exoskeleton device, ReWalk ...

Helius Medical Technologies (Nasdaq:HSDT) announced today that it established Revelation Neuro, a brain-computer interface ...

Stryker (NYSE: SYK) announced today that it is commercially launching the next generation of its Mako surgical robotic ...

Among major medtech stocks, Intuitive Surgical, Boston Scientific and Stryker have had an especially rough week.

Medtronic released positive two-year trial Evolut TAVR results that demonstrated superior valve performance in small aortic ...

Perfuze announced today that it received FDA 510(k) clearance for its Zipline access catheter and secured significant funding ...

Cognixion announced today that it launched a clinical trial evaluating its integrated, wearable augmented reality and BCI ...

Class II recalls — a grade below the most serious Class I recalls — reference a situation in which the use of or exposure to ...